Variagenics Q1 Revenues Rise on Pharmacogenomics Deals

May 01, 2001

NEW YORK, May 1 – Variagenics reported Monday an 11-fold increase in first-quarter revenues to $1.1 million from $100,000 in the year-ago quarter.

Revenues stemmed from the company’s new collaboration on pharmacogenomics with Amgen, as well as its continuing collaborations with Boeringher Ingelheim and Isis Pharmaceuticals.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

WHO Panel Announced

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

Research Reproducibility Scores

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

Tests for All Diagnosed

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

This Week in Science

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.

Main menu